ID NOW™

Abbott’s ID NOW™ is a rapid molecular diagnostic system based on isothermal amplification of nucleic acids for the qualitative detection of infectious diseases. ID NOW™’s unique nucleic acid amplification technology provides molecular results in minutes, allowing you to make effective clinical decisions more quickly.

Its test menu is aimed at respiratory infections of clinical relevance and with a high impact on patient health: Influenza A, Influenza B, Respiratory Syncytial Virus (RSV), Streptococcus group A and Covid-19. Its rapid delivery of results means that this platform can be operated at the point of patient care, providing a molecular diagnostic solution with high sensitivity and specificity, appropriate to the time required by both the patient and the clinician.